Advertisement

Related Videos

Garth Strohbehn, MD, MPhil, on Applied Clinical Pharmacology in a Crisis: Interventional Pharmacoeconomics and COVID-19

Matthew Seymour, MD: A Clinical Trialist’s Perspective

Focus on Optimized Dosing of Ibrutinib Panel Discussion

Clifford A. Hudis, MD: Are Cancer Drug Prices in the U.S. the Problem or the Symptom?

Clinical Trial Design: Statistical Options/Challenges Panel Discussion

Advertisement

Advertisement




Mar
21
Today In Oncology
FDA Approves Chemoimmunotherapy Regimen for Hodgkin Lymphoma
Hypofractionated Locoregional RT in Early Breast Cancer
Melanoma-Specific Survival With Sentinel Lymph Node Biopsy
Breast Cancer Ultrasensitive ctDNA Assay Findings and Outcomes After Neoadjuvant Therapy
AMA Survey Finds Rapid Growth in Physician AI Adoption
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo